Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation treatment in early stage high-risk and advanced endometrial cancer

被引：0
|
作者：
Kim, H.
Kim, J.
Chung, H.
Park, N.
Song, Y.
Kang, S.
Lee, H.
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Konkuk Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.16591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant carboplatin and paclitaxel chemotherapy followed by radiotherapy in high-risk endometrial cancer: A retrospective analysis.
    Bonadio, Renata Rodrigues da Cunha Colombo
    Azevedo, Renata Gondim Meira Velame
    Harada, Guilherme
    da Costa, Samantha Cabral Severino
    Miranda, Vanessa Costa
    de Freitas, Daniela
    Filho, Elias Abdo
    Ferreira, Patricia Alves de Oliveira
    Gabrielli, Flavia
    Estevez-Diz, Maria Del Pilar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Early-stage high-risk endometrial cancer: Adjuvant treatment with chemotherapy and vaginal brachytherapy
    Schuman, S.
    Stine, J.
    Zhao, W.
    Yali, P.
    Wolfson, A.
    Lucci, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S86 - S87
  • [23] Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
    Randall, Marcus E.
    Filiaci, Virginia
    McMeekin, D. Scott
    von Gruenigen, Vivian
    Huang, Helen
    Yashar, Catheryn M.
    Mannel, Robert S.
    Kim, Jae-Weon
    Salani, Ritu
    DiSilvestro, Paul A.
    Burke, James J.
    Rutherford, Thomas
    Spirtos, Nick M.
    Terada, Keith
    Anderson, Penny R.
    Brewster, Wendy R.
    Small, William
    Aghajanian, Carol A.
    Miller, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) : 1810 - +
  • [24] Phase II study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.
    Sugiyama, T
    Omi, H
    Kigawa, J
    Hatae, M
    Suzuki, M
    Tsuda, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 475S - 475S
  • [25] A prospective study of adjuvant carboplatin and paclitaxel chemotherapy and involved field radiation in women with high-risk endometrial cancer
    Lupe, K.
    Kwon, J.
    D'Souza, D.
    Carey, M.
    Gawlik, C.
    Stitt, L.
    Whiston, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S166 - S166
  • [26] Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
    Eldredge-Hindy, Harriet Belding
    Eastwick, Gary
    Anne, Pramila Rani
    Rosenblum, Norman G.
    Schilder, Russell J.
    Chalian, Raffi
    Zibelli, Allison M.
    Kim, Christine H.
    Den, Robert
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2014, 6 (03) : 262 - 270
  • [27] Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
    Fotopoulou, Christina
    El-Balat, Ahmed
    du Bois, Andreas
    Sehouli, Jalid
    Harter, Philipp
    Muallem, Mustafa Z.
    Kraetschell, Robert W.
    Traut, Alexander
    Heitz, Florian
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (06) : 1321 - 1327
  • [28] Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer
    Christina Fotopoulou
    Ahmed El-Balat
    Andreas du Bois
    Jalid Sehouli
    Philipp Harter
    Mustafa Z. Muallem
    Robert W. Krätschell
    Alexander Traut
    Florian Heitz
    Archives of Gynecology and Obstetrics, 2015, 292 : 1321 - 1327
  • [29] Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
    Emeline Moreira
    Eduardo Paulino
    Álvaro Henrique Ingles Garces
    Mariane S. Fontes Dias
    Marcos Saramago
    Flora de Moraes Lino da Silva
    Luiz Claudio Santos Thuler
    Andréia Cristina de Melo
    Medical Oncology, 2018, 35
  • [30] COMPARISON OF TOXICITY AND OUTCOMES OF CONCURRENT RADIOTHERAPY WITH CARBOPLATIN/PACLITAXEL AND CISPLATIN/ETOPOSIDE IN STAGE III NON-SMALL CELL LUNG CANCER
    Liew, Mun Sem
    Sia, Joseph
    Starmans, Maud H. W.
    Tafreshi, Ali
    Harris, Sam
    Feigen, Malcolm
    White, Shane
    Zimet, Allan
    Lambin, Philippe
    Boutros, Paul
    Mitchell, Paul
    John, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S851 - S852
12345